Drug-induced tendinopathy: from physiology to clinical applications.

Joint Bone Spine

Service de Radiologie, Département d'imagerie musculo-squelettique, Cliniques Universitaires Saint-Luc, avenue Hippocrate 10, 1200 Bruxelles, Belgium; Université Paris Diderot, 5, rue Thomas-Mann, 75205 Paris, France.

Published: December 2014

Drug-induced tendon toxicity is rare but often underestimated. To date, four main drug classes have been incriminated in tendinopathies. Quinolones and long-term glucocorticoids are the most widely known, but statins and aromatase inhibitors can also induce tendon damage. The specific pathophysiological mechanisms responsible for drug-induced tendinopathies remain unknown. Proven risk factors have been identified, such as age older than 60 years, pre-existing tendinopathy, and potentiation of toxic effects when several drug classes are used in combination. Mean time to symptom onset varies from a few days with quinolones to several months with statins and several years for long-term glucocorticoid therapy. The most common sites of involvement are the lower limb tendons, most notably the body of the Achilles tendon. The first part of this review discusses tendon anatomy and the pathophysiology and radiological manifestations of tendinopathies. The second part provides details on the main characteristics of each of the drugs classes associated with tendon toxicity.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbspin.2014.03.022DOI Listing

Publication Analysis

Top Keywords

tendon toxicity
8
drug classes
8
tendon
5
drug-induced tendinopathy
4
tendinopathy physiology
4
physiology clinical
4
clinical applications
4
applications drug-induced
4
drug-induced tendon
4
toxicity rare
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!